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Abstract
Background: Studies examining psychosocial and depression assessment programs in maternity settings have not
adequately considered the context in which psychosocial assessment occurs or how broader components of
integrated care, including clinician decision-making aids, may optimise program delivery and its cost-effectiveness. There
is also limited evidence relating to the diagnostic accuracy of symptom-based screening measures used in this context.
The Perinatal Integrated Psychosocial Assessment (PIPA) Project was developed to address these knowledge gaps. The
primary aims of the PIPA Project are to examine the clinical- and cost-effectiveness of two alternative models of
integrated psychosocial care during pregnancy: ‘care as usual’ (the SAFE START model) and an alternative model
(the PIPA model). The acceptability and perceived benefit of each model of care from the perspective of both pregnant
women and their healthcare providers will also be assessed. Our secondary aim is to examine the psychometric properties
of a number of symptom-based screening tools for depression and anxiety when used in pregnancy.
Methods: This is a comparative-effectiveness study comparing ‘care as usual’ to an alternative model sequentially
over two 12-month periods. Data will be collected from women at Time 1 (initial antenatal psychosocial assessment),
Time 2 (2-weeks after Time 1) and from clinicians at Time 3 for each condition. Primary aims will be evaluated using a
between-groups design, and the secondary aim using a within group design.
Discussion: The PIPA Project will provide evidence relating to the clinical- and cost- effectiveness of psychosocial
assessment integrated with electronic clinician decision making prompts, and referral options that are tailored to
the woman’s psychosocial risk, in the maternity care setting. It will also address research recommendations from
the Australian (2011) and NICE (2015) Clinical Practice Guidelines.
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Background
One in five women experience some form of mental
health morbidity during pregnancy and the first postnatal
year (the perinatal period). A large meta-analysis of 28
studies reported that up to 12.7% and 21.9% of women
will experience major depression during pregnancy and in
the first twelve months postpartum [1], respectively, while
up to 21% of women meet diagnostic criteria for at least
one anxiety disorder during pregnancy [2, 3]. Recent
evidence from birth cohorts in France and Australia also
suggest that up to 40% of women with untreated prenatal
depression continue to experience symptoms four and five
years postpartum [4, 5].
The health service systems in place for routine maternity
care in a number of countries have provided a unique op-
portunity to introduce perinatal mental health promotion,
prevention and early intervention programs. In Australia,
routine psychosocial assessment – a broad clinical evalu-
ation of a woman which aims to help facilitate the provision
of comprehensive, quality clinical care – is central to many
of these programs. In the perinatal mental health context,
such an approach encompasses enquiry into a range of risk
and protective factors known to affect perinatal mental
health for both mother and infant, including her current
and past psychological health and social circumstances.
This assessment may be enhanced by the use of relevant
‘screening’ or case detection tools, such as the Edinburgh
Postnatal Depression Scale (EPDS) which asks about symp-
toms of depression occurring in the previous seven days
[6]. The aim of this assessment is to identify the presence
of current symptoms or psychosocial factors known to be
associated with poorer maternal mental health so that
appropriate care can be provided and outcomes for women
improved [7].
In the last decade Australia has become a world leader
in the development of national policy and clinical practice
for perinatal mental health. Examples of key Australian
national initiatives that are inclusive of routine depression
screening and psychosocial assessment include the beyond-
blue National Postnatal Depression Program (2001–2005)
[8], the beyondblue National Action Plan for Perinatal
Mental Health (2008) [9] and the National Perinatal
Depression Initiative (NPDI; 2008–2015), which also
supported the development of Australia’s first national
Clinical Practice Guidelines for Depression and Related
Disorders in the Perinatal Period [7]. The need for such
screening and assessment programs to be well inte-
grated with clinical guidance for appropriate care plan-
ning, and across health care disciplines and sectors, has
been highlighted [10–12].
In Sydney, where the PIPA Project is based, the SAFE
START perinatal mental health policy directive and clin-
ical practice guidelines have been in place at a number of
large public maternity hospitals since 2010 [13–15], with
the Integrated Perinatal Care (IPC) model of care imple-
mented in some metropolitan settings prior to this time
[16]. The SAFE START policy and guidelines specify a
model of perinatal psychosocial assessment that includes
psychosocial assessment at the first antenatal hospital
appointment (the ‘booking-in’ visit), nominates a woman’s
psychosocial ‘risk level’ and recommends further clinical
action where appropriate. For women with higher levels of
risk, clinical review at a multidisciplinary case discussion
(MCD) meeting is required [13–15].
An evaluation of the SAFE START model of care noted
a number of limitations, including an overrepresentation
of ‘false positive’ women discussed at MCD meetings. In
other words, women some were being referred to the
MCD, when these women either did not require fur-
ther assessment or referral, or could have instead been fur-
ther monitored by their midwives, without discussion at
MCD [17]. One potential reason for this high rate of
referrals to the MCD meetings is the lower threshold set by
SAFE START for further referral, which may result in
inadvertent over-servicing, reduced system efficacy, in-
creased costs through service duplication, and in-
creased anxiety for women being incorrectly identified
as ‘at risk’ [18].
In response to these limitations in the SAFE START
model, an alternative approach – the Perinatal Integrated
Psychosocial Assessment (PIPA) model – was developed
by Austin and colleagues and will be compared with SAFE
START (care as usual) in the current study.
Methods
Clinical context and study definitions
At the initial antenatal booking in appointment, midwives
at the participating site decide whether each woman in
their care requires a psychosocial referral based on their
responses to the routine psychosocial assessment. Once a
woman has been flagged for psychosocial referral, the
mental health midwife and senior social worker allocate
women to the relevant service/s at a weekly ‘triage’
meeting, according to their psychosocial presentation.
Referral can be made to one or more on-site components
of the maternity psychosocial service, including the multi-
disciplinary case discussion (MCD) meeting, psychiatry
clinic, mental health midwife, social work, drug and alco-
hol support services and antenatal psycho educational and
therapy groups (see Fig. 1).
For the purposes of the PIPA Project, the following
definitions will apply:
Referral: will be defined as the initial referral made by
the midwife to one or more of the on-site support
options. NOTE: Referrals to services external to the
participating site are outside the scope of data collection
for the current project, as are referrals made at later
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antenatal appointments (i.e., not the initial booking-in
appointment).
‘Correct’ referral: a clinically appropriate referral made
by the midwife, as determined by the consensus opinion
of senior psychosocial clinicians at the weekly ‘triage’
and MCD meetings.
‘Incorrect’ referral: a clinically inappropriate referral
made by the midwife, as determined by the consensus
opinion of senior psychosocial clinicians at the weekly
‘triage’ and MCD meetings.
Aims
The PIPA Project will address three primary aims and
one secondary aim, as follows:
Primary Aim 1: Clinical effectiveness outcomes: To com-
pare the two models of care in relation to: i) the propor-
tion of women identified as ‘at risk’ and referred by the
midwife conducting the initial psychosocial assessment to
the various referral pathways (e.g., mental health midwife,
social work, MCD meeting), stratified by comparable
levels of risk in each model of care (see Table 1); and ii)
the proportion of ‘correct’ and ‘incorrect’ referrals from
the initial psychosocial assessment in each model.
Primary Aim 2: Cost-effectiveness outcomes: To quantify:
i) the cost per ‘correct’ and ‘incorrect’ referral made at the
initial psychosocial assessment, for each model of care; ii)
the incremental cost per ‘correct’ referral made and the
incremental cost per ‘incorrect’ referral averted by the
PIPA model compared to the SAFE START model; and,
iii) the budgetary implications of implementing the PIPA
model at the participating site, based on number of
women assessed.
Primary Aim 3: Consumer perspectives: To compare
the acceptability and perceived benefit of each model of
care from the perspective of both pregnant women and
their healthcare providers.
Secondary Aim: Psychometric properties of screening
tools: To examine the sensitivity, specificity, positive and
negative predictive values, and positive and negative like-
lihood ratios of the EPDS [6], ‘Whooley’ depression
questions [19, 20], the Generalized Anxiety Disorder
Scale [GAD-7] and its short form [GAD-2] [21], and
Matthey Generic Mood Questionnaire (MGMQ) [22]
when used during pregnancy, using the Mini Inter-
national Neuropsychiatric Interview v6.0 [23] (MINI) as
the gold standard.
Hypotheses
We hypothesize that the PIPA model of care will be at
least 15% more clinically effective, and will be more eco-
nomically efficient and acceptable, than ‘care as usual’.
Secondly, we expect that each of the screening measures
will have acceptable psychometric characteristics when
used in this population of pregnant women.
Design
This is a comparative-effectiveness study which will
compare ‘care as usual’ (the SAFE START model) to an
alternative model (the PIPA model) sequentially over a
36 month period (see Fig. 2). It will employ a mixed
Fig. 1 Psychosocial care pathway
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methods design. The primary aims will be evaluated
using a between-groups design, comparing the two
models of care on a range of outcomes. The secondary
aims will be evaluated using a within group design.
Psychosocial assessment models of care
A summary of the key features of the SAFE START and
PIPA models of care are presented in Table 1.
SAFE START model (care as usual)
This model of care recommends that all women complete
the EPDS and SAFE START psychosocial questions at the
initial antenatal booking-in appointment [13]. A paper-
based version of the EPDS is completed by the woman
and the total score and score on question 10 are manually
scored by the midwife and recorded on a state-wide
administrative database (ObstetriX; to be superseded by
eMaternity), whereas the psychosocial questions are
Table 2 Data collection schedule and measures
Measure Time 1
All women (routinely collected data)
Time 2
Consenting women only
Time 3
Health professionals only
Demographic informationa X
EPDSa X X
Psychosocial assessmenta X
Routine referral informationb,c X
Feedback survey (women)d X
Costing data X X
Feedback survey; observational data; key informant
interviews; focus groups (health professionals)b,c,e
X
Whooley questionsf X
GAD-2f,g X
MGMQf,g X
MINIf,g X
Interval questionf,g X
Brief help seeking itemsf,g X
EPDS Edinburgh Perinatal Depression Scale, GAD-2 Generalized Anxiety Disorder Scale-2items, MGMQ Matthey Generic Mood Questionnaire, MINI Mini International
Neuropsychiatric Interview (v6.0; mood and anxiety disorder modules only; Data will be used to address: aAll aims; bPrimary Aim 1 (clinical effectiveness); cPrimary
Aim 2 (cost effectiveness); dPrimary Aim 3 (pregnant women perspectives); ePrimary Aim 3 (health care provider perspectives); fSecondary Aim (psychometric
evaluation). gCompleted by women allocated to the PIPA model of care only
Table 1 Comparison of key features of the SAFE START and PIPA models of integrated psychosocial assessment
Model of integrated psychosocial assessment
SAFE START model
(Care as usual)
PIPA model
(Alternative model)
Psychosocial assessment
measures
EPDS, SAFE START psychosocial questions EPDS, ANRQ-R (psychosocial questions); clinician concerns
Psychosocial risk levels Three levels of psychosocial risk, defined as:
Level 1: no specific vulnerabilities or risk
Level 2: one or more risk factors of variable severity
and significance including, but not limited to, low
supports, multiple birth, financial stress, isolation,
‘mild-moderate’ depression or anxiety, history of
mental health problem, young age.
Level 3: one or more of four complex risk factors
(domestic violence, involvement with child
protection services, substance misuse, severe
mental illness)
Six levels of psychosocial risk, defined as:
No risk: ANRQ-R = 0; EPDS < 13 (Q10 = 0); no clinician concerns.
No risk on ANRQ-R (ANRQ-R = 0) but clinician concerns and/or
EPDS = 13 or 14.
Low risk: ANRQ-R = 1–24 (excluding e,g., significant mental health
historya) and EPDS < 15 (Q10 = 0).
Medium risk: ANRQ-R = 1–24 (including e,g., significant mental
health historya) and EPDS < 15 (Q10 = 0).
Medium-high risk: ANRQ-R ≥25 (excluding any ‘complex’ risk
factorsb) or combination of ‘social’ risk factorsc or EPDS ≥15
(Q10 = 0) or childhood trauma and neglect.
High risk: ANRQ-R >25 and other ‘social’ risk factorsc or any
‘complex’ risk factor (s)b or EPDS Q10 ≥ 1.
MCD meeting referral
threshold
Levels 2 and 3 High risk
MCD multidisciplinary case discussion meeting, ANRQ-R Antenatal Risk Questionnaire-Revised, EPDS Edinburgh Postnatal Depression Scale
a‘significant’ mental health history: involving professional help and/or had functional impact
b‘Complex’ risk factors : homelessness or housing instability; domestic violence; substance misuse; contact with child protection services
c‘Social’ risk factors: young maternal age (less than 20 years); no partner; booking-in appointment at >20 weeks gestation
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administered face-face by the midwife and responses elec-
tronically recorded in the database. The psychosocial
questions cover seven key domains of risk: (1) (lack of) so-
cial supports; (2) recent stressors in the previous
12 months; (3) anxious personality style or low self-
esteem; (4) history of mental health problems; (5) history
of childhood abuse; (6) contact with child protective ser-
vices or having a child living in the care of another person;
and (7) current or recent domestic violence. Based on re-
sponses to these questions and the EPDS, women fall into
one of three SAFE START psychosocial risk levels: Level 1
(no specific vulnerabilities or risk); Level 2 (endorsing one
or more of a broad range of risk factors of variable severity
and significance) or Level 3 (endorsing one or more com-
plex risk factors, where ‘complex’ risk implies a high de-
gree of psychosocial morbidity associated with greater risk
of mental health disorder, lack of engagement with ser-
vices and risk of poor parenting and infant outcomes, in-
cluding risk of harm to the infant).
Perinatal Integrated Psychosocial Assessment (PIPA) model
The PIPA model of care comprises three key electronic
elements:
1) Administration of the Antenatal Risk Questionnaire-
Revised (ANRQ-R) questionnaire (covering a range of
Fig. 2 Flow chart for the PIPA Project. 1 No data collection in Study Year 2 due to state-level upgrade of administrative data platform at the
participating site; Training in the PIPA model will take place in the final month of Year 2; 2 Time 1 = approx. 12–16 weeks’ gestation; 3 Time
2:=2 weeks post-Time 1; 4 Excluded from Time 2 if: declined study Expression of Interest (EoI); EoI not asked at booking-in visit; declined participation
when contacted at time of Time 2; did not meet inclusion criteria at Time 2; not contacted at Time 2 due to staffing/resource limitations; 5 Completed
by women in Group 2 only; 6 To examine healthcare provider perspectives, survey, observational and key informant interview data will be collected
during the final 6 months of the allocation periods for Group 1 and Group 2. Focus groups will be held approx. 3-months after the implementation of
the PIPA model of care
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known psychosocial risk factors) and the EPDS
(including four additional questions to aid more
guided exploration of recent thoughts of self-harm,
among women who endorse EPDS question 10) by
the midwife, with responses recorded in eMaternity;
2) A computer-based clinician decision-support
algorithm, which generates the woman’s
psychosocial risk profile and self-harm risk scores
(based on the ANRQ-R and EPDS), summarises
the presence/combinations of identified risk
factors and articulates six psychosocial risk levels,
ranging from No Risk to High Risk;
3) Immediate referral prompts for the midwife
conducting the assessment. These clinician prompts
are embedded within eMaternity, and are tailored
to the woman’s psychosocial risk profile and the
on-site services available.
The ANRQ-R is a revised version of the validated
ANRQ [24], incorporating the following psychosocial
risk domains: possible mental health history (identifying
significant episodes in terms of impact on function and/
or seeking treatment); history of physical, sexual or emo-
tional abuse; current/recent intimate partner violence;
level of practical supports; quality of relationship with
mother (in childhood) and current partner (if partnered);
anxious or perfectionistic personality style; current or
recent substance use; and significant levels of stress in
the last 12 months as well as questions relating to
(homelessness or housing instability, single or teen par-
enthood, contact with child protection services). The
ANRQ-R adheres to the recommendations of the SAFE
START model, in terms of the core set of psychosocial
variables that are assessed [14].
Key differences between the SAFE START and PIPA models
of care
While the two psychosocial assessments are similar in
content, PIPA differs from the SAFE START in a number
of ways. The PIPA model: 1) considers in full all possible
psychosocial risk factors identified across the booking visit
and provides a cumulative measure of their impact by
generating a total score on the ANRQ-R; 2) measures the
severity of a number of risk factors (whereas SAFE START
identifies only the presence or absence of these risk fac-
tors); 3) auto-scores the questionnaires, eliminating man-
ual scoring errors arising in this context [25]; 4) includes
additional structured questions to explore self-harm on
the EPDS; 5) enables the midwife to document clinical
concerns not elicited by the questionnaires, (e.g., the
woman’s presentation at interview). This ‘Clinician Con-
cerns’ option duly recognizes the importance of clinicians’
judgment and provides an avenue to refer a woman to the
mental health midwife even if no risk is identified on the
structured questionnaires.
Setting
The site for the PIPA Project is the Royal Hospital for
Women (RHW), a large teaching hospital in metropol-
itan Sydney, Australia, with approximately 4000 births
per year [26].
During the first 12 months of the PIPA Project,
women who attend the participating site for their first
midwife-led routine antenatal visit will receive care as
usual (SAFE START model), while women who attend
for their antenatal booking-in visit in the last 12 months
of the study will receive the alternative PIPA model of
care. There will be an interval of approximately 12 months
to allow for the implementation of a new state-wide ad-
ministrative database (eMaternity), which will incorporate
the PIPA model and one month of staff training for the
PIPA model. During this time, women attending the
hospital will continue to receive care as usual, though
no study data will be collected (see Fig. 2).
Time points for data collection
As shown in Fig. 2, data collected at two time points (Time
1 and Time 2) will inform the assessment of clinical- and
cost-effectiveness outcomes, as well as women’s perceptions
of the acceptability and perceived benefit of each model of
care (Primary Aims). Data collected at these time points
will also be used to examine the psychometric properties of
a range of screening tools when used in pregnancy
(Secondary Aim). Time 1 will be the initial psychosocial
assessment (generally conducted at the first antenatal
booking-in visit; approx.12 – 16 weeks gestation) and
Time 2 will be approximately 2 weeks post-Time 1.
A range of data collection activities involving healthcare
providers will comprise Time 3. Midwives will be
approached to complete an emailed or paper-based
survey (as per respondent preference) in the final six
months of the data collection period for each model of care.
Semi-structured key informant interviews with other health-
care professionals will also be conducted during this time.
These data will be used to address the study’s clinical- and
cost-effectiveness outcomes, as well as health care provider
perceptions of the acceptability and perceived benefit of
each model of care. Additional administrative and clinical
data will be collected during periods of observation by the
Research Officer throughout the allocation periods for each
model of care, and focus groups will be held approximately
3 months after the introduction of the PIPA model.
Consent processes for women attending the participating
site
Permission to waive patient consent for the collection of
Time 1 data has been granted by the governing Human
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Research Ethics Committee. For Time 2, women who
express an interest in participating in this component of
the study (indicated to the midwife at the time of the
initial psychosocial assessment) will be subsequently
contacted by research staff. At this time, women who
agree to take part will give their informed consent.
Participant eligibility and expected sample sizes
The estimated sample sizes for Time 1 and Time 2 is
predicated on the number of births at the participating
site (approximately 4000 women per annum), the propor-
tion of these women who complete the initial psychosocial
assessment (approx. 85%) and expected rates of participa-
tion at Time 2 (approx. 15-20% of all English-speaking
women attending the site for their booking in visit).
Time 1: De-identified information relating to all women
who attend the study site for their antenatal care will be
included in the study database for Time 1, with an esti-
mated total sample size of 7000 women completing a
routine psychosocial assessment during the data collec-
tion periods for each model of care (3500 women per
SAFE START and PIPA models of care).
Time 2: Only women who, at Time 1, respond ‘yes’ to an
expression of interest (EoI) to be involved at Time 2 will be
contacted by the Research Officer. Women who have not
completed the routine psychosocial assessment during
pregnancy, who are clients of the hospital’s Indigenous
Midwifery service (due to differences in the models of care
and service delivery) and/or who are unable to complete
the Time 2 questionnaires in English will not be contacted
to take part in Time 2. The anticipated total sample size for
Time 2 is 1300 women (650 per model of care).
Time 3: Study participants will include up to 40 health-
care providers who are responsible for conducting the
psychosocial assessment or providing emotional and men-
tal health care for women who attend the participating site
for antenatal care (representatives from psychiatry, social
work, mental health nursing, midwifery, administration,
hospital data management). All relevant staff will be
invited to contribute data to Time 3 (via one or more of
survey data, observational data, key informant interviews;
focus groups); however, staff that provided care under only
one of the models (i.e., SAFE START or PIPA) will be
ineligible for focus group participation. The numbers of
health care professionals anticipated to contribute data for
each mode of data collection are: survey data (est. n = 25),
observational data (est. n = 5–10), key informant inter-
views (est. n = 5–10) and focus groups (est. n = 8–16
individuals).
To enable economic assessments to be completed,
data relating to time spent by midwives at booking, time
spent by administrative staff collecting and distributing
files for new bookings (approx. est. n = 30 files per staff
member) will be recorded under both models of care.
Data on the time spent discussing referrals to the social
work department (n = 120), the mental health midwife
(n = 120) and weekly MCD (n = 50) will also be recorded
for each model of care. Information relating to the clin-
ical ‘correctness’ of these referrals will also be collected:
this will be determined by the consensus opinion of key
senior clinicians at the weekly MCD (perinatal psych-
iatrist, mental health midwife, senior midwife, and senior
social worker) or the weekly file review (‘triage’) meeting
of the mental health midwife and senior social worker.
Data sources, measures and procedures
Time 1: Initial psychosocial assessment conducted at the
antenatal ‘booking in’ visit
The hospital data management system (ObstetriX and
subsequently eMaternity) will be used to identify all
women who attended the participating site during the
data collection periods for the PIPA Project, and for
whom a routine psychosocial assessment was completed.
The Time 1 dataset will include: date of booking in visit
and psychosocial assessment; gestation and maternal age
at this time; maternal date of birth; estimated date of
delivery; partner status; gravidity (including reason for
pregnancy loss, where available); parity; country of birth;
physical health conditions; type of conception; model of
maternity care; EPDS: total and Q10 scores; EPDS: item
level responses (SAFE START only); psychosocial ques-
tions: item level responses; psychosocial questions: total
score (PIPA only); referral/s indicated as a result of the
psychosocial assessment (yes/no); referral/s indicated as
a result of the psychosocial assessment (specified; PIPA
only); language; interpreter needed; financial class (pub-
lic, private or overseas patient); and Time 2 Expression
of Interest response (yes/no). Time 1 data will be ex-
tracted by the data manager at the participating site at
approximately weekly intervals, for all women allocated
to the SAFE START and PIPA models of care.
Time 2: Two weeks post-time 1
Women who consent to participation at Time 2 will
complete the EPDS [6], the ‘Whooley’ questions [19]
followed by a third ‘help’ question [20], the Generalized
Anxiety Disorder Scale [GAD-7] [21], the Matthey Generic
Mood Questionnaire (MGMQ) [22], an ‘interval’ question
to assess perceived change in emotional wellbeing at Time
2 [27] and the Mini International Neuropsychiatric Inter-
view v6.0 [M.I.N.I.; mood and anxiety disorder modules
only] [23]. Women will also complete a short survey cover-
ing the acceptability of the psychosocial questions and
assessment process.
‘Key Survey’™ will be used as the platform for data
collection for all Time 2 measures except the M.I.N.I.,
which will be collected using infrastructure provided by
Medical Outcomes Systems (to whom the online M.I.N.I.
Reilly et al. BMC Pregnancy and Childbirth  (2017) 17:236 Page 7 of 11
is copyrighted). Alternatively, these questionnaires will be
administered by phone by the Research Officer verbatim,
with participant responses captured in the project-specific
‘Key Survey’ and MINI instruments.
Time 3: various data collection points during the model of
care allocation periods
Survey for health professionals: Study-specific survey
questions will address a range of issues related to the
experience of healthcare professionals (in particular,
midwives) in providing psychosocial care to women dur-
ing pregnancy, including: level of comfort in asking the
psychosocial questions; level of confidence in discussing
responses to the psychosocial assessment and (if required)
referral and support options; time spent administering the
initial psychosocial assessment; time spent initiating any
referrals; ease of use of computer-based assessment tool;
and utility of referral advice and the psychosocial sum-
mary report (listing key issues and referral prompts arising
from the psychosocial assessment), for each model of care.
‘Key Survey’™ will be used as the platform for data col-
lection for the healthcare professional feedback ques-
tionnaire. Paper versions of the questionnaires will be
provided to healthcare professionals who do not have
internet access, or who would prefer to complete the
measures in hardcopy.
Observational data and key informant interviews: The
following information will be collected for each model of
care: time spent by clinical and administrative staff on
administrative tasks directly related to psychosocial care,
including collecting and distributing files for new book-
ings where a psychosocial referral was made; time spent
‘triaging’ and allocating these files as appropriate; time
spent on case discussion at the MCD for new bookings;
and other relevant administrative tasks.
As part of the Time 3 data collection, the Research
Officer will also attend the weekly psychosocial ‘triage’
and MCD meetings to collate referral pathway data for
women in each model of care. This will include informa-
tion on the number and proportion of women for whom
a referral was made from their initial psychosocial assess-
ment, and the number and proportion of women consid-
ered ‘correct’ and ‘incorrect’ referrals. The Research Officer,
in consultation with the relevant on-site departments and
clinicians, will collate this information for both models
of care. This process will also be facilitated by the
Research Officer observing/shadowing the day-day
activities of key staff.
Focus groups: Health care professionals providing psy-
chosocial care for pregnant women at the study site will
be invited to participate in a study-specific focus group.
These may include midwives, social workers, mental health
midwives and psychiatrists. The focus groups will explore
participants’ experiences of providing the alternative
models of psychosocial care, including (but not limited
to) time and ease of administration, understanding of
risk levels (including nomenclature) and perception of
care quality for the woman. A question guide will be
used to facilitate discussion and will be informed by key
themes from existing literature, consultation with ex-
perts and feedback captured in the Time 3 surveys.
Each focus group will be approximately 60–90 min in
duration. Discussion will be recorded with the permis-
sion of participants using digital audio recorders and
will be transcribed verbatim.
Resource consumption and unit resource cost estimates
The economic evaluations will be informed by survey
data, observational data, key informant interviews and
focus groups during the trial period and will be completed
at Time 3. Bottom up costing methods based on the
principle of opportunity costs forgone will be employed to
capture the direct costs of identifying ‘correct’ and ‘incor-
rect’ referrals cases. The Research Officer will time each
activity associated with completing psychosocial assess-
ment and administrative tasks associated with the initi-
ation of referrals to various site-based support services
(see Box). This will allow the allocation of costs for each
activity for inclusion in the cost-effectiveness analysis. The
salary costs applied for each unit of activity will be taken
from NSW Health Service Awards. Overhead costs will
not be applied because they are equivalent between the
two models of care. Because the PIPA Project has been
designed to primarily inform decision making around
effectiveness, efficiency and acceptability of a psychosocial
screening program from the perspective of the maternity
sectors, indirect patient costs associated with travel etc
will not be included, nor will the costs associated with
downstream, clinical care or interventions and the broader
burden associate with mental illness. Costs will be pre-
sented in constant Australian dollars (AUD) (Table 2).
Statistical analysis
Clinical effectiveness, acceptability and perceived benefit
analysis
Effectiveness outcomes (Primary Aim 1), including the
proportion of women identified at particular psychosocial
risk levels (as defined in the SAFE START and PIPA
models of care) and proportion of women considered to
be ‘correct’ or ‘incorrect’ referrals in each care model will
be analysed using chi-square and independent-samples
t-tests (or Mann Whitney U tests, as appropriate). This
approach will also be used to examine the acceptability
and perceived benefit of the SAFE START and PIPA
models (Primary Aim 3). Initial checking of statistical
assumptions (normality, multicollinearity, examination
of outliers) will be undertaken. Chi-square analysis of
subgroups of women based on risk status may also be
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explored. Clinically significant differences between the two
models will be based upon obtaining at least medium effect
sizes or absolute percentage differences of at least 15%.
Cost-effectiveness analysis
The primary outcome variable for the cost-effectiveness
analysis (Primary Aim 2) will be the proportion of ‘cor-
rect’ referrals initiated and ‘incorrect’ referrals averted.
The incremental costs and effects of SAFE START com-
pared to PIPA will be expressed as the incremental cost-
effectiveness ratio (ICER). The ICER combines the net
changes in effects with the net change in costs between
two strategies providing a relative estimate of the cost-
effectiveness of the PIPA program relative to the SAFE
START program. The ICER per ‘correct’ referral made
and per ‘incorrect’ referral averted will be estimated
using mean costs and effects and represented with 95%
confidence intervals for the ICERs using non-parametric
bootstrapping techniques. One-way and multivariate
probability sensitivity analysis using Monte Carlo simu-
lations across the cost and effect distributions will be
undertaken to investigate uncertainty around the ICERs.
Based on number of women screened and proportion of
‘correct’ and ‘incorrect’ referrals identified, the economic
evaluation will allow a budget impact analysis to be
undertaken to determine the costs of running SAFE
START and PIPA at other maternity hospitals.
Focus groups (qualitative data)
The qualitative focus group data will be analysed by two
members of the research team with qualitative expertise
using inductive thematic content analysis consistent with
an interpretive descriptive approach. Data will be en-
tered into NVivo. Transcribed data will be coded first by
using an open coding process to organise the data by
identifying broad thematic patterns [28]. The data will
then be read and re-read to enable classification into
categories and specific themes [28, 29].
Psychometric properties of screening tools
To examine the psychometric properties of the EPDS,
‘Whooley’ questions, GAD-2 and MGMQ when used
during pregnancy (Secondary Aim), we will conduct a
receiver operator curve analysis to calculate the area
under the curve and sensitivity, specificity, positive and
negative predictive values and positive and negative like-
lihood ratios negative likelihood ratios of each measure,
using the M.I.N.I. as the gold standard (mood and anxiety
disorder modules only). Consistent with other studies of
this type a value of 0.5 will be added if a 2x2 cell contains
zero, in order to calculate the likelihood ratios and
associated confidence intervals. In addition the various
screening measures will be compared with each other,
using each measure’s screen-positive threshold (where
these thresholds are available).
Study status
This study is ongoing. Data collection for the SAFE
START model of care (care as usual) is complete. Data
collection for the PIPA model of care (alternative model)
is scheduled to commence in the first half of 2017.
Discussion
The value of an integrated approach to depression screen-
ing in facilitating the connection between assessment pro-
cesses and care pathways has been demonstrated in the
general population literature [30–32] and is gaining in-
creased attention in the perinatal context [16, 33–35].
However, existing perinatal studies, like general population
studies, have been limited to depression screening alone, ra-
ther than more comprehensive psychosocial assessment
(which is inclusive of, but not limited to, depression screen-
ing). This is the first study of its kind to incorporate an
evaluation of how broader components of integrated care,
including electronic clinician decision-making aids and re-
ferral processes, may influence the outcomes of a program.
The PIPA Project will contribute substantially to the
literature by providing evidence for the value of structured
psychosocial assessment tools and electronic decision mak-
ing algorithms in a large scale study. The present study will
provide crucial insight into the most cost-effective use of
health resources and information about potential sources of
cost reduction (via improved resource efficiency in the
public maternity sector). Through its secondary aim,
the PIPA Project will also respond to calls made in the
Australian and UK Clinical Practice Guidelines for further
research evaluating the psychometric properties of screen-
ing tools for depression and anxiety in pregnant women.
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